8 Publikationen in 2025
Kumulativer IF: 181,6
Mittelwert IF: 24,04

1. Vascular (dys)function in the failing heart
Liberale L, Duncker D J, Hausenloy D J, Kraler S, Bøtker H E, Podesser B K, Heusch G, Kleinbongard P
Nat Rev Cardiol; doi: 10.1038/s41569-025-01163-w    (Impact Factor = 44,2)

2. Ischaemic conditioning: a renaissance with wider perspectives?
Heusch G, Kleinbongard P
Eur Heart J; doi.org/10.1093/eurheartj/ehaf205    (Impact Factor = 35,6)

3. It takes more than omics to identify a cardioprotective mechanism.
Heusch G, Kleinbongard P
Cardiovasc Res; 10.1093/cvr/cvaf052    (Impact Factor = 13,3)

4. Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC
Sean M. Davidson, Ioanna Andreadou, Charalambos Antoniades, Jozef Bartunek, Cristina Basso, Bianca J.J.M. Brundel, Robert A. Byrne, Gemma Chiva-Blanch, Paula da Costa Martins, Paul C. Evans, Henrique Girão, Zoltan Giricz, Can Gollmann-Tepeköylü, Tomasz Guzik, Mariann Gyöngyösi, Norbert Hübner, Michael Joner, Petra Kleinbongard, Thomas Krieg, Elisa Liehn, Rosalinda Madonna, Ange Maguy, Melanie Paillard, Maurizio Pesce, Steffen E. Petersen, Gabriele G. Schiattarella, Joost P.G. Sluijter, Sabine Steffens, Katrin Streckfuss-Bömeke, Matthias Thielmann, Art Tucker, Sophie Van Linthout, William Wijns, Johann Wojta, Joseph C. Wu, Cinzia Perrino
Cardiovasc Res; 10.1093/cvr/cvaf023    (Impact Factor = 13,3)

5. The Enigmata of Cardioprotection With SGLT2 Inhibition.
Heusch G, Kleinbongard P
JACC Basic Transl Sci; 10:62-64    (Impact Factor = 7,2)

6. The spleen in ischaemic heart disease
Heusch G, Kleinbongard P
Nat Rev Cardiol; 10.1038/s41569-024-01114-x    (Impact Factor = 44,2)

7. From Ca2+ dysregulation to heart failure: β-adrenoceptor activation by RKIP postpones molecular damages and subsequent cardiac dysfunction in mice carrying mutant PLNR9C by correction of aberrant Ca2+-handling.
Brand T, Baumgarten BT, Denzinger S, Reinders Y, Kleindl M, Schanbacher C, Funk F, Gedik N, Jabbasseh M, Kleinbongard P, Dudek J, Szendroedi J, Tolstik E, Schuh K, Krüger M, Dobrev D, Cuello F, Sickmann A, Schmitt JP, Lorenz K.
Pharmacol Res; 211:107558    (Impact Factor = 10,5)

8. Involvement of (trained) immunity in cardioprotection
Heusch G, Kleinbongard P
Cardiovasc Res.; doi: 10.1093/cvr/cvaf170    (Impact Factor = 13,3)